Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page
- Check6 days agoChange DetectedNew update dates 2026-04-08 and 2026-04-09 were added, and 2026-04-01 and 2026-04-02 were removed. This reflects chronology updates to the study record.SummaryDifference0.1%

- Check13 days agoChange DetectedThe study record shows new update entries for 2026-04-02 and 2026-04-01 and deletions for 2026-03-25 and 2026-03-24.SummaryDifference0.1%

- Check20 days agoChange DetectedAdministrative updates were made to the study record dates, adding 2026-03-25 and 2026-03-24 and removing 2026-03-18 and 2026-03-19.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded Informed Consent Form PDFs for Phase I, Phase 2A, and Phase 2B under Study Documents. The revision version is v3.5.0.SummaryDifference0.9%

- Check35 days agoChange DetectedNew update entries dated 2026-03-11 and 2026-03-12 for revision v3.4.3 were added, and the prior revision v3.4.2 was removed. The visible study content and page functionality appear unaffected.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded update dates 2026-03-04 and 2026-03-05 and removed 2026-02-24 and 2026-02-25 from the page's update history.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.